Melatonin, autophagy and intestinal bowel disease

Current Pharmaceutical Design

Volumn 20, Issue 30, 2014, Pages 4816-4827

  Talero, Elena ^a   García Mauriño, Sofía ^a   Motilva, Virginia ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Autophagy; Chronic inflammation; Colitis; Inflammatory bowel disease; Melatonin

Indexed keywords

CASPASE 3; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYCLOOXYGENASE 2; FREE RADICAL; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; MELATONIN; NITRIC OXIDE; NITROGEN DERIVATIVE; PATTERN RECOGNITION RECEPTOR; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; SCAVENGER; STRESS ACTIVATED PROTEIN KINASE; X BOX BINDING PROTEIN 1; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CELL ADHESION MOLECULE; INDUCIBLE NITRIC OXIDE SYNTHASE; TOLL LIKE RECEPTOR;

AUTOPHAGY; CD4+ T LYMPHOCYTE; CELL DEATH; CROHN DISEASE; ENDOPLASMIC RETICULUM STRESS; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; GENETIC ASSOCIATION; HEREDITY; HUMAN; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; IRRITABLE COLON; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; COLITIS; DISEASE ASSOCIATION; EXPERIMENTAL STUDY; IMMUNOMODULATION; INTESTINE EPITHELIUM; LYMPHOCYTE COUNT;

AUTOPHAGY; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; MELATONIN;

EID: 84906262789     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612819666131119110835     Document Type: Review

References (204)

1. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006; 12: S3-S9.
2. Nanau RN, Neuman MG. Metabolome and inflammasome in inflammatory bowel disease. Transl Res 2012; 160: 1-28.
3. Talero E, Sánchez-Fidalgo S, Villega SI, et al. Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis 2011; 17: 696-710.
4. Watson AJM, Hughes KR. TNF-a-induced intestinal epithelial cell shedding: implications for intestinal barrier function. Ann N Y Acad Sci 2012; 1258: 1-8 c.
5. Yamamoto-Furusho JK, Barnich N, Hisamatsu T, Podolsky DK. MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function. Inflamm Bowel Dis 2010; 16: 736-42.
6. Abreu MT. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr Gastroenterol Rep 2002; 4: 481-89.
7. Neurath MF, Weigmann B, Finotto S, et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 2002; 195: 1129-43.
8. Montgomery SM, Ekbom A. Epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 2002; 18: 416-20.
9. Itzkowitz SH. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am 2006; 35: 553-71.
10. Chapkin RS, Davidson LA, Ly L, et al. Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J Nutr 2007; 137: 200S-204S.
11. Sarra M, Monteleone I, Stolfi C, et al. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm Bowel Dis 2010; 16: 1332-39.
12. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1756-67.
13. Stappenbeck TS, Rioux JD, Mizoguchi A, et al. Crohn disease: A current perspective on genetics, autophagy and immunity. Auto-phagy 2011; 7: 355-74.
14. Martin B, Hirota K, Cua DJ, et al. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009; 31: 321-30.
15. Fukata M, Arditi M. The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol 2013; 6: 451-63.
16. Rubino SJ, Selvanantham T, Girardin SE, et al. Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol. 2012; 24: 398-404.
17. Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011; 43: 1066-73.
18. Van Limbergen J, Nimmo ER, Russell RK, et al. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy. Hum Mol Genet 2007; 16: 2175-86.
19. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
20. Franke A, McGovern DPB, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature Genetic 2010; 42: 1118-25.
21. Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010; 11: 55-62.
22. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces auto-phagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16: 90-97.
23. Cario E. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction. Curr Opin Gas-troenterol 2008; 24: 725-32.
24. Huang J, Lam GY, Brumell JH. Autophagy signaling through reactive oxygen species. Antioxid Redox Signal 2011; 14: 2215-31.
25. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Gen 2007; 39: 207-211.
26. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Gen 2007; 39: 596-604.
27. Zhang S, Zhao X, Zhang D. Cellular and molecular immunopatho-genesis of ulcerative colitis. Cell Mol Immunol 2006; 3: 35-40.
28. Degn SE, Thiel S. Humoral pattern-recognition and the complement system. Scand J Immunol. 2013. doi: 10.1111/sji.12070, [Epub ahead of print].
29. Haller D. Intestinal epithelial cell signalling and host- derived negative regulators under chronic inflammation: to be or not to be activated determines the balance towards commensal bacteria. Neuro-gastroenterol Motil 2006; 18: 184-199.
30. Fritz JH, Girardin SE, Fitting C, et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Europ J Immunol 2005; 35: 2459-70.
31. Lala S, Ogura Y, Osborne C, et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003; 125: 47-57.
32. Wullaert A. Role of NF-kappaB activation in intestinal immune homeostasis. International J Med Microbiol 2010; 300: 49-56.
33. Barreau F, Meinzer U, Chareyre F, et al. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS ONE 2007; 2: e523.
34. Watanabe T, Asano N, Murray PJ, et al. Muramyl dipeptide activation of nucleotide- binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest 2008; 118: 545-59.
35. Watanabe T, Kitani A, Murray PJ, et al. Nucleotide binding oli-gomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006; 25: 473-85.
36. Keller M, Rüegg A, Werner S, Beer H-D: Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008; 132: 818-31.
37. Allen IC, TeKippe EM, Woodford RMT, et al. The NLRP3 in-flammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 2010; 207: 1045-56.
38. Zaki MH, Boyd KL, Vogel P, et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010; 32: 379-91.
39. Hirota SA, Ng J, Lueng A, et al. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 2011; 17: 1359-72.
40. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390-407.
41. Gutierrez O, Pipaon C, Inohara N, et al. Induction of Nod2 in mye-lomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002; 277: 41701-05.
42. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nature Reviews Immunol 2009; 9: 778-88.
43. Tergaonkar V. NFkappaB pathway: a good signalling paradigm and therapeutic target. Int J Biochem Cell Biol 2006; 38: 1647-53.
44. Wang S, Liu Z, Wang L, et al. NF-kappaB signalling pathway, inflammation and colorectal cancer. Cell Mol Immunol 2009; 6: 327-34.
45. Sartor RB, Hoentjen F. Proinflammatory cytokines and signalling pathways in intestinal innate immune cells. In: Mestecky J, et al. Eds, Mucosal Immunology. Philadelphia, Elsevier 2005; p681-701.
46. Martin H. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutat Res. 2010; 690: 57-63.
47. Guri AJ, Mohapatra SK, Horne WT et al. The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease. BMC Gastroenterol 2010; 10: 60.
48. Bassaganya-riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr 2006; 25: 454-65.
49. Bassaganya-riera J, Reynolds K, Martino-catt S, et al. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroen-terology 2004; 127: 777-91.
50. Lewis JD, Lichtenstein GR, Deren JJ, et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroen-terology 2008; 134: 688-95.
51. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417-26.
52. Franchi L, Amer A, Body-Malapel M, et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 2006; 7: 576-82.
53. Miao EA, Alpuche-Aranda CM, Dors M, et al. Cytoplasmic flagel-lin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 2006; 7: 569-75.
54. Zhernakova A, Festen EM, Franke L, et al. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Gen 2008; 82: 1202-10.
55. Chen GY, Núñez G. Inflammasomes in intestinal inflammation and cancer. Gastroenterology 2011; 141: 1986-99.
56. Lee JW, Kim WH, Yeo J, et al. ER stress is implicated in mito-chondrial dysfunction-induced apoptosis of pancreatic beta cells. Mol Cells 2010; 30: 545-49.
57. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Ann Rev Immunol 2010; 28: 573-621.
58. Takemoto K, Miyata S, Takamura H, et al. Mitochondrial TRAP1 regulates the unfolded protein response in the endoplasmic reticulum. Neurochem Int 2011; 58: 880-7.
59. Kaser A, Martínez-Naves E, Blumberg RS. Endoplasmic reticulum stress: implications for inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 2010; 26: 318-26.
60. Back SH, Lee K, Vink E, et al. Cytoplasmic IRE1alpha-mediated XBP1 mRNA splicing in the absence of nuclear processing and en-doplasmic reticulum stress. J Biol Chem 2006; 281: 18691-706.
61. Kaser A, Adolph TE, Blumberg RS. The unfolded protein response and gastrointestinal disease. Semin Immunopathol. 2013; 35: 307-19.
62. Nakamura T, Furuhashi M, Li P, et al. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 2010; 140: 338-48.
63. Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38: 209-23.
64. Becker C, Watson AJ, Neurath MF. Complex Roles of Caspases in the Pathogenesis of Inflammatory Bowel Disease. Gastroenterology 2012. doi: 10.1053/ j.gastro.2012.11.035, [Epub ahead of print].
65. Green DR, Oberst A, Dillon CP, et al. RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell 2011; 44: 9-16.
66. Cajochen C, Chellappa S, Schmidt C. What keeps us awake? The role of clocks and hourglasses, light, and melatonin. Int Rev Neuro-biol 2010; 93: 57-90.
67. Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol 2011; 17: 3888-98.
68. Pozo D, García-Mauriño S, Guerrero JM, Calvo JR. mRNA expression of nuclear receptor RZR/RORalpha, melatonin membrane receptor MT, and hydroxindole-O-methyltransferase in different populations of human immune cells. J Pineal Res 2004; 37: 48-54.
69. Reiter RJ, Tan DX, Terron MP, Flores LJ, Czarnocki Z. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007; 54: 1-9.
70. Konturek SJ, Konturek PC, Brzozowski T. Melatonin in gastropro-tection against stress-induced acute gastric lesions and in healing of chronic gastric ulcers. J Physiol Pharmacol 2006; 57(Suppl 5): 51-66.
71. Jaworek J, Nawrot-Porabka K, Leja-Szpak A, et al. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J Physiol Pharmacol 2007; 58(Suppl 6): 65-80.
72. Mozaffari S, Abdollahi M. Melatonin, a promising supplement in inflammatory bowel disease: a comprehensive review of evidences. Curr Pharm Des 2011; 17: 4372-8.
73. Mozaffari S, Rahimi R, Abdollahi M. Implications of melatonin therapy in irritable bowel syndrome: a systematic review. Curr Pharm Des 2010; 16: 3646-55.
74. Tanaka T, Yasui Y, Tanaka M, Tanaka T, Oyama T, Rahman KM. Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats. Chem Biol Interact 2009; 177: 128-36.
75. Sánchez-Barceló EJ, Mediavilla MD, Tan DX, Reiter RJ. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem 2010; 17: 2070-95.
76. Funderburg NT, Stubblefield Park SR, Sung HC, et al. Circulating CD4+ and CD8+ T cells are activated in IBD and are associated with plasma markers of inflammation. Immunology 2013. doi: 10.1111/imm.12114, [Epub ahead of print].
77. Yamanishi H, Murakami H, Ikeda Y, et al. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells. J Immunol 2012; 188: 2164-72.
78. Tasdemir S, Parlakpinar H, Vardi N, Kaya E, Acet A. Effect of endogen-exogenous melatonin and erythropoietin on dinitrobenzene sulfonic acid-induced colitis. Fundam Clin Pharmacol 2013; 27: 299-307.
79. Qin X. Etiology of inflammatory bowel disease: a unified hypothesis. World J Gastroenterol 2012; 18: 1708-22.
80. Mei Q, Yu JP, Xu JM, Wei W, Xiang L, Yue L. Melatonin reduces colon immunological injury in rats by regulating activity of macrophages. Acta Pharmacol Sin 2002; 23: 882-6.
81. Trivedi PP, Jena GB. Melatonin Reduces Ulcerative Colitis-Associated Local and Systemic Damage in Mice: Investigation on Possible Mechanisms. Dig Dis Sci. 2013. doi: 10.1007/s10620-013-2831-6, [Epub ahead of print].
82. Esposito E, Mazzon E, Riccardi L, Caminiti R, Meli R, Cuzzocrea S. Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis. J Pineal Res 2008; 45: 166-73.
83. Tahan G, Gramignoli R, Marongiu F, et al. Melatonin expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic-acid-induced colitis in rats. Dig Dis Sci 2011; 56: 715-20.
84. Li JH, Yu JP, Yu HG, et al. Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis. Mediators Inflamm 2005; 2005: 185-93.
85. Mazzon E, Esposito E, Crisafulli C, et al. Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. J Pineal Res 2006; 41: 363-73.
86. Cuzzocrea S, Mazzon E, Serraino I, et al. Melatonin reduces dini-trobenzene sulfonic acid-induced colitis. J Pineal Res 2001; 30: 1-12.
87. Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol 2012; 22: 557-66.
88. Clark IM, Swingler TE, Sampieri CL, Edwards DR. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2008; 40: 1362-78.
89. Dong WG, Mei Q, Yu JP, Xu JM, Xiang L, Xu Y. Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis. World J Gastroenterol 2003; 9: 1307-11.
90. Mei Q, Xu JM, Xiang L, Hu YM, Hu XP, Xu ZW. Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro. Postgrad Med J 2005; 81: 667-72.
91. Siggers RH, Hackam DJ. The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases. Cell Mol Life Sci 2011; 68: 3623-34.
92. Martin SJ, Henry CM, Cullen SP. A perspective on mammalian caspases as positive and negative regulators of inflammation. Mol Cell 2012; 46: 387-97.
93. Necefli A, Tulumoglu B, Giris M, et al. The effect of melatonin on TNBS-induced colitis. Dig Dis Sci 2006; 51: 1538-45.
94. Akcan A, Kucuk C, Sozuer E, et al. Melatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acid-induced colitis of rats. World J Gastroenterol 2008; 14: 918-24.
95. Bonnefont-Rousselot D, Collin F. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 2010; 278: 55-67.
96. Reiter RJ, Paredes SD, Manchester LC, Tan DX. Reducing oxida-tive/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44: 175-200.
97. Zhu H, Li YR. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med (Maywood). 2012; 237: 474-80.
98. Pentney PT, Bubenik GA. Melatonin reduces the severity of dex-tran-induced colitis in mice. J Pineal Res 1995; 19: 31-9.
99. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabó C. Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur J Pharmacol 1998; 342: 67-76.
100. Fischer TW, Kleszczyhski K, Hardkop LH, Kruse N, Zillikens D. Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2'-deoxyguanosine) in ex vivo human skin. J Pineal Res 2013; 54: 303-12.
101. Nosál'ová V, Zeman M, Cerná S, Navarová J, Zakálová M. Protective effect of melatonin in acetic acid induced colitis in rats. J Pineal Res 2007; 42: 364-70.
102. Chojnacki C, Wisniewska-Jarosinska M, Walecka-Kapica E, Klupinska G, Jaworek J, Chojnacki J. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis. J Physiol Pharmacol 2011; 62: 327-34.
103. Mann S. Melatonin for ulcerative colitis? Am J Gastroenterol 2003; 98: 232-3.
104. Calvo JR, Guerrero JM, Osuna C, Molinero P, Carrillo-Vico A. Melatonin triggers Crohn's disease symptoms. J Pineal Res 2002; 32: 277-8.
105. Maldonado MD, Calvo JR. Melatonin usage in ulcerative colitis: a case report. J Pineal Res 2008; 45: 339-40.
106. Takeshige K, Baba M, Tsuboi S, Noda T, Ohsumi Y. Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J Cell Biol 1992; 119: 301-11
107. Huang WP, Klionsky DJ. Autophagy in yeast: a review of the molecular machinery. Cell Struc Funct 2002; 27: 409-20
108. Sigmond T, Barna J, Toth ML, et al. Autophagy in Caenorhabditis elegans. Methods Enzymol 2008; 451: 521-40
109. Tian Y, Li Z, Hu W, et al. C. elegans screen identifies autophagy genes specific to multicellular organisms. Cell. 2010; 141: 1042-55
110. Baehrecke EH. Autophagic programmed cell death in Drosophila. Cell Death Differ 2003; 10: 940-5
111. McPhee CK, Baehrecke EH. Autophagy in Drosophila mela-nogaster. Biochim Biophys Acta 2009; 1793: 1452-60
112. Kim J, Klionsky DJ. Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells. Annu Rev Biochem 2000; 69: 303-42
113. Fimia GM, Piacentini M. Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci 2010; 67: 1581-8
114. Bassham DC. Function and regulation of macroautophagy in plants. Biochim Biophys Acta 2009; 1793: 1397-403
115. Klionsky DJ, Cregg JM, Dunn WA, et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell 2003; 5: 539-45
116. Uchiyama Y, Shibata M, Koike M, Yoshimura K, Sasaki M. Auto-phagy-physiology and pathophysiology. Histochem Cell Biol 2008; 129:407-20
117. Klionsky DJ, Codogno P, Cuervo AM, et al. A comprehensive glossary of autophagy-related molecules and processes. Autophagy 2010; 6: 438-48
118. Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature 2010; 466: 68-76
119. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Oh-sumi Y. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol 2000; 150: 1507-13
120. Hosokawa N, Hara T, Kaizuka T, et al. Nutrientdependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20: 1981-91
121. Jung CH, Jun CB, Ro SH, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20: 1992-2003
122. Funderburk SF, Wang QJ, Yue Z. The Beclin1-VPS34 complex-at the crossroads of autophagy and beyond. Trends Cell Biol 2010; 20: 355-62
123. Ohsumi, Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2001; 2: 211-6
124. Massey DC, Parkes M. Genome-wide association scanning highlights two autophagy genes, ATG16L1 and IRGM, as being significantly associated with Crohn's disease. Autophagy 2007; 3: 649-51
125. Klionsky DJ, Abeliovich H, Agostinis P, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008; 4: 151-175
126. Legakis JE, Yen WL, Klionsky DJ. A cycling protein complex required for selective autophagy. Autophagy 2007; 3: 422-32
127. Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010; 40: 280-93
128. Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002; 4: 648-57
129. Jung CH, Ro SH, Cao J, Otto NM, Kim DH. mTOR regulation of autophagy. FEBS Lett 2010; 584: 1287-95
130. Wei Y, Pattingre S, Sinha S, Bassik M, Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 2008; 30: 678-88
131. Shaw R.J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol 2009; 196: 65-80
132. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013; 368: 651-62
133. Nixon RA, Wegiel J, Kumar A, et al. Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study. J Neuropathol Exp Neurol 2005; 64: 113-22
134. Sarkar S, Ravikumar B, Rubinsztein C. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration. Methods Enzymol 2009; 453: 83-110
135. Cheung ZH, Ip NY. Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives. J Neurochem 2011; 118: 317-25
136. Takalo M, Salminen A, Soininen H, Hiltunen M, Haapasalo A. Protein aggregation and degradation mechanisms in neurodegenera-tive diseases. Am J Neurodegener Dis 2013; 2: 1-14
137. Nishino I. Autophagic vacuolar myophaties. Curr Neurol Neurosci Rep 2003; 3: 64-9
138. Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol 2004; 14: 70-7
139. Morselli E, Galluzzi L, Kepp O, et al. Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta 2009; 1793: 1524-32
140. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-52
141. Shih DQ, Targan SR, McGovern D. Recent advances in IBD patho-genesis: Genetics and immunology. Curr Gastroenterol Rep 2008; 10: 568-75
142. Ishiara S, Aziz MM, Yuki T, Kazumori H, Kinoshita Y. Inflammatory bowel disease: review from the aspect of genetics. J Gastroen-terol 2009; 44: 1097-108
143. Kaser A, Blumberg RS. Autophagy, microbial sensing, endoplas-mic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology 2011; 140:1738-47
144. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469: 323-35
145. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011; 140: 1807-16
146. Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A. Crohn's disease: NOD2, autophagy and ER stress converge. Gut 2011; 60: 1580-8
147. Hisamatsu T, Kanai T, Mikami Y, Yoneno K, Matsuoka K, Hibi T. Immune aspects of the pathogenesis of inflammatory bowel disease. Pharmacol Ther 2013; 137: 283-97
148. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008; 134: 743-56
149. Schmid D, Münz C. Innate and adaptive immunity through auto-phagy. Immunity 2007; 27: 11-21
150. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004; 15: 1101-11
151. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474: 298-306
152. Yorimitsu T, Klionsky DJ. Endoplasmic reticulum stress: a new pathway to induce autophagy. Autophagy 2007; 3: 160-2
153. He C, Klionsky DJ. Regulation mechanisms and signalling pathways of autophagy. Annu Rev Genet 2009; 43: 67-93
154. Verfaillie T, Salazar M, Velasco G, Agostinis P. Linking ER stress to autophagy: potential implications for cancer therapy. Int J Cell Biol 2010; doi:10.1155/2010/930509
155. Bertolotti A, Wang X, Novoa I, et al. Increased sensitivity to dex-tran sodium sulfate colitis in IRE1beta-deficient mice. J Clin Invest 2001; 107: 585-93
156. McCarroll SA, Huett A, Kuballa SD, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 2008; 40: 1107-12
157. Mizushima N, Sugita H, Yoshimori T, Ohsumi Y. A new protein conjugation system in human the counterpart of the yeast Apg12p conjugation system essential for autophagy. J Biol Chem 1998; 273: 33889-92
158. Saitoh T, Fujita N, Jang MH, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008; 456: 264-8
159. Cadwell K, Liu J, Brown S, et al. A unique role for autophagy and Atg16L1 in Paneth cells in murine and human intestine. Nature 2008; 456: 259-63
160. Ouellette AJ. Paneth cells and innate immunity in the crypt micro-environment. Gastroenterology 1997; 113: 1779-84
161. Singh SB, Davis S, Taylor GA, Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006; 313: 1438-41
162. Bafica A, Feng CG, Santiago HC, et al. The IFN-inducible GTPase LRG47 (Irgm1) negatively regulates TLR4-triggered proinflamma-tory cytokine production and prevents endotoxemia. J Immunol 2007; 179: 5514-22
163. Brest P, Corcelle EA, Cesaro A, et al. Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer. Curr Mol Med 2010; 10: 486-502
164. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces auto-phagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16: 90-7
165. Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003; 124: 1265-76
166. Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004; 5: 104-12
167. Sanjuan MA, Dillon CP, Tait SW, et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007; 450: 1253-7
168. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004; 119: 753-66
169. Kirkegaard K, Taylor MP, Jackson WT. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat Rev Mi-crobiol 2004; 2: 301-14
170. Saleh M. The machinery of Nod-like receptors: refining the paths to immunity and cell death. Immunol Rev 2011; 243: 235-46
171. Zhou D, Li P, Lin Y, et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 2005; 22: 571-81
172. Dengjel J, Schoor O, Fischer R, et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Nat Acad Sci USA 2005; 102: 7922-7
173. Caballero B, Vega-Naredo I, Sierra V, et al. Autophagy upregula-tion and loss of NF-kappaB in oxidative stress-related immunodefi-cient SAMP8 mice. Mech Ageing Dev 2009; 130: 722-30
174. Guo Y, Wang J, Wang Z, Yang Y, Wang X, Duan Q. Melatonin protects N2a against ischemia/reperfusion injury through autophagy enhancement. J Huazhong Univ Sci Technolog Med Sci 2010; 30: 1-7
175. Kim CH, Kim KH, Yoo YM. Melatonin-induced autophagy is associated with degradation of MyoD protein in C2C12 myoblast cells. J Pineal Res 2012; 53: 289-97
176. Choi SI, Kim KS, Oh JY, Jin JY, Lee GH, Kim EK. Melatonin induces autophagy via an mTOR-dependent pathway and enhances clearance of mutant-TGFBIp. J Pineal Res 2013; 54: 361-72
177. Coto-Montes A, Tomas-Zapico C. Could melatonin unbalance the equilibrium between autophagy and invasive processes? Autophagy 2006; 2: 126-8
178. Esrefoglu M, Güi M, Ates B, et al. Ultrastructural clues for the protective effect of melatonin against oxidative damage in cerulein-induced pancreatitis. J Pineal Res 2006; 40: 92-7
179. Kimball SR, Abbas A, Jefferson LS. Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signalling pathways in H4IIE hepatoma cells through inhibition of Ras. J Pineal Res 2008; 44: 379-86
180. Koh PO. Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway. Neurosci Lett 2008; 444: 74-8
181. Kongsuphol P, Mukda S, Nopparat C, et al. Melatonin attenuates methamphetamine-induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells. J Pineal Res 2009; 46: 199-206
182. Nopparat C, Porter JE, Ebadi M, Govitrapong P. The mechanism for the neuroprotective effect of melatonin against methanpheta-mine-induced autophagy. J Pineal Res 2010; 49: 382-9
183. Yoo Ym, Jeung EB. Melatonin suppresses cyclosporine A-induced autophagy in rat pituitary GH3 cells. J Pineal Res 2010; 48: 204-11
184. Han F, Chen YX, Lu YM, et al. Regulation of the ischemia-induced autophagy-lysosome processes by nitrosative stress in endothelial cells. J Pineal Res 2011; 51: 124-35
185. Reiter RJ. Melatonin: lowering the high price of free radicals. News Physiol Sci 2000; 15: 246-50
186. Coto-Montes A, Boga JA, Rosales-Corral S, Fuentes-Broto L, Tan DX, Reiter RJ. Role of melatonin in the regulation of autophagy and mitophagy: A review. Mol Cell Endocrinol 2012; 361: 12-23
187. García-Mauriño S, Alcaide A, Dominguez C. Pharmacological control of autophagy: Therapeutic perspectives in inflammatory bowel disease and colorectal cancer. Curr Pharm Des 2012; 18: 3853-73
188. Chang CF, Huang HJ, Lee HC, Hung KC, Wu RT, Lin AMY. Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and a-synuclein aggregation. J Pineal Res 2012; 52: 312-21
189. Zhou H, Chen J, Lu X, et al. Melatonin protects against rotenone-induced cell injury via inhibition of Omi and Bax-mediated autophagy in Hela cells. J Pineal Res 2012; 52: 120-7
190. Park S, Lee SK, Park K, et al. Beneficial effects of endogenous and exogenous melatonin on neural reconstruction and functional recovery in an animal model of spinal cord injury. J Pineal Res 2012; 52: 107-19
191. Jeong JK, Moon MH, Lee YJ, Seol JW, Park SY. Melatonin-induced autophagy protects against human prion protein-mediated neurotoxicity. J Pineal Res 2012; 53: 138-46
192. Liu C, Jia Z, Zhang X, et al. Involvement of melatonin in auto-phagy-mediated mouse hepatoma H22 cell survival. Int Immuno-pharmacol 2012; 12: 349-401
193. García JJ, Piñol-Ripoll G, Martínez-Ballarín E, et al. Melatonin reduces membrane rigidity and oxidative damage in the brain of SAMP8 mice. Neurobiol Aging 2011; 32: 2045-54
194. Vega-Naredo I, Caballero B, Sierra V, et al. Melatonin modulates autophagy through a redox-mediated action in female Syrian hamster Harderian gland controlling cell types and gland activity. J Pineal Res 2012; 52: 80-92
195. Motilva V, García-Mauriño S, Talero E, Illanes M. New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin. J Pineal Res 2011; 51: 44-60
196. Lee IH, Cao L, Mostoslavsky R, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Nat Acad Sci USA 2008; 105: 3374-79
197. Lan F, Caciedo JM, Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008; 283: 27628-35
198. Jung-Hynes B, Reiter RJ, Ahmad N. Sirtuins, melatonin and cir-cadian rhythms: building a bridge between aging and cancer. J Pineal Res 2010, 48: 9-19
199. Menassol JB, Tautou C, Collet A, et al. The effect of an intracere-broventricular injection of metformin or AICAR on the plasma concentrations of melatonin in the ewe: potential involvement of AMPK? BMC Neurosci 2011; 12: 76
200. Bruzzone S, Parenti MD, Grozio A, et al. Rejuvenating sirtuins: the rise of a new family of cancer drug targets. Curr Pharm Des 2013; 19: 614-23
201. Cheng Y, Cai L, Jiang P, et al. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells. Eur J Pharmacol; 2013: 219-29
202. Kwon KJ, Kim HJ, Shin CY, Han SH. Melatonin potentiates the neuroprotective properties of resveratrol against beta-amyloid-induced neurodegeneration by modulating AMP-activated protein kinase pathways. J Clin Neurol 2010; 6: 127-37
203. Koh W, Jeong SJ, Lee HJ, et al. Melatonin promotes puromycin-induced apoptosis with activation of caspase-3 and 5'-adenosine monophosphate-activated kinase-alpha in human leukemia HL-60 cells. J Pineal Res 2011; 50: 367-73
204. Zaouali MA, Boncompagni E, Reiter RJ, et al. AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail. J Pineal Res 2013; 1: 65-78.